Portfolio Update

4 July 2007

                  FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC                  

                                (the "Company")                                

                      QUARTERLY STATEMENT OF INVESTMENTS                       

In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:

  * Investments valuing greater than 5% of the Company's gross assets comprise
    the following:
   
Company Name                                        Value of       % of Total  
                                                 Investment at      Portfolio  
                                                                     Assets    
                                                  30 June 2007                 
                                                                               
NOVARTIS CHF0.50 REGD                              20,308,961         6.61     
                                                                               
WYETH COM USD0.333                                 15,404,222         5.01     

  * The ten largest investments held by the Company comprise the following:
   
Company Name                                  Value of Investment   % of Total 
                                                       at           Portfolio  
                                                                      Assets   
                                                  30 June 2007                 
                                                                               
NOVARTIS CHF0.50 REGD                              20,308,961          6.61    
                                                                               
WYETH COM USD0.333                                 15,404,222          5.01    
                                                                               
GEN-PROBE INC USD0.0001                            14,755.874          4.80    
                                                                               
GENENTECH INC COM STK USD0.02 NPV                  13,868,208          4.51    
                                                                               
AMGEN COM USD0.0001                                13,418,078          4.36    
                                                                               
JOHNSON & JOHNSON COM USD1                         13,195,654          4.29    
                                                                               
PFIZER INC COM USD0.05                             12,915,468          4.20    
                                                                               
TAKEDA PHARMACEUTICAL CO NPV                       12,497,669          4.07    
                                                                               
GENZYME CORP GENERAL DIVISION COM USD0.01          11,330,625          3.69    
                                                                               
BIOGEN IDEC COM USD0.0005                          11,325,417          3.68    

                                   - ENDS -                                    

For further information please contact:

Mark Pope, Company Secretary

Frostrow Capital LLP

Telephone: [phone]